Enzalutamida en este contexto (CPRC): ¿cuáles son los pacientes? - page 34

Drug resistance due to continued or up regulated signaling

from the AR

Seruga B, et al. Nat Rev Clin Oncol 2011

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,24,25,26,27,28,29,30,31,32,33 35,36,37,38,39,40,41,42